(0.30%) 5 115.09 points
(0.31%) 38 357 points
(0.34%) 15 982 points
(-0.91%) $83.09
(5.77%) $2.03
(0.36%) $2 355.60
(0.44%) $27.66
(4.01%) $959.10
(-0.23%) $0.933
(-0.38%) $10.98
(-0.54%) $0.796
(1.69%) $93.43
@ $24.74
発行日: 15 2月 2024 @ 05:58
リターン: -34.75%
前回のシグナル: 2月 15 - 02:05
前回のシグナル:
リターン: 1.73 %
Live Chart Being Loaded With Signals
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions...
Stats | |
---|---|
本日の出来高 | 116 024 |
平均出来高 | 363 040 |
時価総額 | 617.38M |
EPS | $0 ( 2024-02-29 ) |
次の収益日 | ( $0 ) 2024-05-07 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -18.77 |
ATR14 | $0.0230 (0.14%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-15 | Toloue Masoud | Sell | 1 120 | Common Stock |
2024-04-01 | Donnelly William P | Buy | 525 | Common Stock |
2024-04-01 | Meister Paul M | Buy | 630 | Common Stock |
2024-04-01 | Hlavinka Sarah E. | Buy | 630 | Common Stock |
2024-04-01 | Olson Laurie J | Buy | 1 000 | Common Stock |
INSIDER POWER |
---|
90.58 |
Last 96 transactions |
Buy: 1 249 474 | Sell: 53 877 |
ボリューム 相関
Quanterix Corp 相関
10 最も負の相関 | |
---|---|
PLMR | -0.83 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Quanterix Corp 相関 - 通貨/商品
Quanterix Corp 財務諸表
Annual | 2023 |
収益: | $121.14M |
総利益: | $69.42M (57.30 %) |
EPS: | $-0.860 |
FY | 2023 |
収益: | $121.14M |
総利益: | $69.42M (57.30 %) |
EPS: | $-0.860 |
FY | 2022 |
収益: | $104.95M |
総利益: | $46.24M (44.05 %) |
EPS: | $-2.61 |
FY | 2021 |
収益: | $110.56M |
総利益: | $61.73M (55.83 %) |
EPS: | $-1.580 |
Financial Reports:
No articles found.
Quanterix Corp
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。